CyBorD: stellar response rates in AL amyloidosis
Author:
Affiliation:
1. PAVIA UNIVERSITY HOSPITAL SAN MATTEO
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/119/19/4343/1352167/zh801912004343.pdf
Reference12 articles.
1. Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis.;Mikhael;Blood,2012
2. Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival.;Venner;Blood,2012
3. The repertoire of lambda light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44.;Perfetti;Blood,2012
4. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway.;Shi;Proc Natl Acad Sci U S A,2010
5. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.;Dispenzieri;J Clin Oncol,2004
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Successes in translation;Amyloid;2024-07-02
2. Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study;Scandinavian Journal of Clinical and Laboratory Investigation;2024-05-02
3. Comprehensive Perspective Towards the Management of Proteinopathies by Elucidating Protein Misfolding and Aggregation;CNS & Neurological Disorders - Drug Targets;2024-02
4. Effect of the Presence of t(11;14) for Patients With AL Amyloidosis Treated With Bortezomib-Containing Regimens: Experience From the Amyloidosis Program of Calgary;Clinical Lymphoma Myeloma and Leukemia;2023-10
5. Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey;Rheumatology;2023-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3